Patents by Inventor Nina Skuban

Nina Skuban has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF MIGALOSTAT IN REDUCING THE RISK OF CEREBROVASCULAR EVENT IN PATIENTS WITH FABRY DISEASE
    Publication number: 20220087993
    Abstract: Provided are methods for the treatment of Fabry disease in a patient and/or reducing the risk of reducing the risk of a cerebrovascular (CBV) event in a patient having Fabry disease. Certain methods relate to the treatment of ERT-experienced or ERT-nave Fabry patients. Certain methods comprise administering to the patient about 100 mg to about 150 mg free base equivalent of migalastat for reducing the risk of a CBV event.
    Type: Application
    Filed: January 22, 2020
    Publication date: March 24, 2022
    Applicant: Amicus Therapeutics, Inc.
    Inventors: Nina Skuban, Hjalmar Lagast
  • Methods Of Treating Fabry Disease
    Publication number: 20210251972
    Abstract: Provided are methods for the treatment of Fabry disease in a patient, such as reducing the risk of composite clinical outcomes. Also provided are methods for assessing various symptoms of Fabry disease such as gastrointestinal symptoms. Also provided are methods of evaluating treatment therapies for Fabry disease.
    Type: Application
    Filed: February 10, 2021
    Publication date: August 19, 2021
    Applicant: Amicus Therapeutics, Inc.
    Inventor: Nina Skuban
  • Methods Of Enhancing And/Or Stabilizing Cardiac Function In Patients With Fabry Disease
    Publication number: 20200222377
    Abstract: Provided are methods for the treatment of Fabry disease in a patient. Certain methods relate to the treatment of ERT-experienced or ERT-naïve Fabry patients. Certain methods comprise administering to the patient about 100 mg to about 150 mg free base equivalent of migalastat for enhancing and/or stabilizing cardiac function.
    Type: Application
    Filed: August 28, 2018
    Publication date: July 16, 2020
    Applicant: Amicus Therapeutics, Inc.
    Inventors: Jeff Castelli, Jay Barth, Nina Skuban